Share this article
TUCSON, Ariz., May 19, 2021 /PRNewswire/
Critical Path Institute (C-Path) today announced the appointment of Robert M. Califf, MD, MACC, head of Clinical Policy and Strategy for Google parent company Alphabet s Verily Life Sciences and Google Health divisions, to C-Path s Board of Directors. Califf served as the U.S. Food and Drug Administration (FDA) Commissioner under President Barack Obama s administration from 2016-2017.
Robert M. Califf, MD, MACC
A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.
C-Path Welcomes Alphabet Clinical Policy and Strategy Head, Former FDA Commissioner to Board prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.